The Nordic Exchange welcomes CellaVision to First North

Trading in CellaVision shares will commence today on First North in Sweden. Including CellaVision, First North now comprises 95 companies. CellaVision AB develops and markets products for the health care sector, enabling blood cell analysis and quality assurance of morphology diagnosis. “We warmly welcome CellaVision to First North. CellaVision is the eighteenth company to join First North this year and the company is a valuable contribution to our Health Care sector”, says Jenny Rosberg, President of Company Services at OMX. Remium AB is Certified Adviser for CellaVision. A round lot of shares in CellaVision, whose short name is CEVI, amounts to 500 and the company is included in the Health Care sector. For further information, please contact Jonas Rodny, OMX Nordic Exchange +46 8 405 72 67 About OMX | OMX is a leading expert in the exchange industry. Through the Nordic Exchange, OMX offers access to approximately 80 percent of the Nordic and Baltic securities market. The Nordic Exchange is a term used for marketing purposes and is not a legal entity. It describes the common offering from the Helsinki Stock Exchange, Copenhagen Stock Exchange, Stockholm Stock Exchange, Iceland Stock Exchange, Tallinn Stock Exchange, Riga Stock Exchange and Vilnius Stock Exchange. OMX integrated technology solutions cross the transaction chain enabling efficient securities transactions for over 60 exchange organizations in more than 50 countries. OMX is a Nordic Large Cap company in the Financials sector on the OMX Nordic Exchange. For more information, please visit www.omxgroup.com.